Article Information
History
- July 7, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Orna Mor1,3,*,
- Michal Mandelboim1,3,*,
- Shay Fleishon1,
- Efrat Bucris1,
- Dana Bar-Ilan1,
- Michal Linial2,
- Yaniv Lustig1,
- Israel National Consortium for SARS-CoV-2 sequencing§,
- Ella Mendelson1,3 and
- Neta S. Zuckerman1,†
- 1Central Virology Laboratory, Public Health Services, Ministry of Health, Sheba Medical Center, Tel-Hashomer, 52621, Israel
- 2Department of Biological Chemistry, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 91904, Israel
- 3Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel
- ↵†Corresponding author:
Neta S. Zuckerman, Central Virology Laboratory, Israel Ministry of Health, Chaim Sheba Medical Center, Tel-Hashomer, 52621, Tel: +972-3-530-2341, email: neta.zuckerman{at}sheba.health.gov.il
↵* These authors contributed equally to the manuscript
Posted July 07, 2021.
The rise and fall of an emerging SARS-CoV-2 variant with the spike protein mutation L452R
